journal articles
LETTER TO THE EDITOR : FROM REGULATORY APPROVAL TO CLINICAL PRACTICE: REAL-WORLD ELIGIBILITY FOR ANTI-AMYLOID MONOCLONAL ANTIBODIES IN AN ITALIAN DEMENTIA-CARE NETWORK
Giovanna Zamboni, Manuela Tondelli, Giulia Vinceti, Chiara Gallingani, Zeno Bercini, Aurora Barbieri, Chiara Carbone, Najara Iacovino, Silvia Cossutti, Daniela Ballotta, Simone Salemme, Annalisa Chiari
CITATION:
Giovanna Zamboni ; Manuela Tondelli ; Giulia Vinceti ; Chiara Gallingani ; Zeno Bercini ; Aurora Barbieri ; Chiara Carbone ; Najara Iacovino ; Silvia Cossutti ; Daniela Ballotta ; Simone Salemme ; Annalisa Chiari (2026): Letter to the Editor: From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network. The Journal of Prevention of Alzheimer’s Disease (JPAD). https://doi.org/10.1016/j.tjpad.2026.100655